INDRA statements for KCNV1
This page allows you to curate the loaded statements. For more information please see the
manual
.
Statements
Expand All
databases
phosphosite
cbn
pc11
biopax
bel_lc
signor
biogrid
lincs_drug
tas
hprd
trrust
ctd
virhostnet
phosphoelm
drugbank
omnipath
|
geneways
tees
isi
trips
rlimsp
medscan
sparser
eidos
reach
reading
NOG
affects
KCNV1
3
|
Transcriptionally active
NOG
increases the amount of
KCNV1
.
3 / 3
3
|
➶
biopax:ctd
No evidence text available
27188386
➶
biopax:ctd
No evidence text available
27188386
➶
biopax:ctd
No evidence text available
27188386
KCNV1
affects
MAP6
|
1
KCNV1
activates
MAP6
.
1 / 1
|
1
➶
reach
"The frameshift mutation in
KCNV1
in patient ASD_14 produces a
stop
codon shortly after, resulting in a prematurely truncated protein and abolishing the last cytoplasmatic domain."
25969726